A medication commonly prescribed to treat fungal infections in lung transplant recipients may wind up posing some unexpected risks.

At one time, many people thought indoor tanning meant a healthy glow year-round. Today, more and more people may be realizing that this isn’t so.

As awareness about the dangers of sun exposure and skin cancer rises, the hope is that skin cancer rates will decrease. New evidence, however, suggests that rates may not be on the decline.

Spending lots of time under the sun's harmful rays can cause skin patches called actinic keratoses (AKs). In some cases, these scaly, rough patches can turn into skin cancer, so doctors usually recommend removing them. But what's the best way to remove them?

Dermatologists use a number of observational and laboratory methods to evaluate suspicious skin marks when looking for cancer. But a new study suggests simply asking a patient to evaluate itchiness or pain can help doctors make informed decisions.

Years of research and health education have made it known that the more sun you get, the higher the odds of eventually developing skin cancer. And sunburns could boost that risk even further.

Side effects involving skin damage have been reported in patients taking voriconazole for fungal infections. Some patients using voriconazole long-term have developed skin cancer.

Skin cancers that are not melanoma are typically curable. A common type of skin cancer, though, can spread and become lethal, new research has found.

Why do certain medications come with a warning that they can make people more sensitive to ultraviolet light? It’s because too much sun while on those meds can raise skin cancer risks.

Skin cancer rates have been on the rise for years. The best way to prevent skin cancer is to protect the skin from sunlight and avoid tanning beds.